Asset Details
Do you wish to reserve the book?
Evaluation of red cell distribution width-to-platelet ratio and other laboratory markers in staging Fontan-associated liver disease
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Evaluation of red cell distribution width-to-platelet ratio and other laboratory markers in staging Fontan-associated liver disease
Do you wish to request the book?
Evaluation of red cell distribution width-to-platelet ratio and other laboratory markers in staging Fontan-associated liver disease
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Evaluation of red cell distribution width-to-platelet ratio and other laboratory markers in staging Fontan-associated liver disease
2025
Overview
Fontan-associated liver disease (FALD) is a common complication in patients with Fontan circulation.
We aimed to evaluate the red blood cell distribution width-to-platelet ratio (RPR) index as a non-invasive marker for assessing FALD severity, given its reported usefulness in in conditions such as hepatitis.
This retrospective, cross-sectional study included adult Fontan patients. Laboratory tests, liver elastography, and hemodynamic parameters were analyzed.
Fifty-six patients (24 females, 43%; median age 24 years, interquartile range [22-28]) were enrolled. Patients were grouped by liver stiffness (LS) stage: METAVIR ≤ F2 (22 patients, 39%) and > F2 (34 patients, 61%). The RPR index was significantly higher in the > F2 group (0.08 vs. 0.12,
= 0.02), along with FIB-4 (0.68 vs. 1.06) and APRI (0.36 vs. 0.57). RPR correlated positively with liver stiffness (
= 0.27), total bilirubin (
= 0.43), cystatin C (
= 0.36), and creatinine (
= 0.38) but not with NT-proBNP, pulmonary artery pressure, or maximal oxygen consumption. The ROC curve analysis for predicting LS > F2 showed an AUC of 0.74 (95% CI: 0.61-0.87), comparable to FIB-4. Moreover, in the logistic regression model that accounted for age, gender, height, body weight, and systemic chamber morphology, RPR showed a significant association with LS > F2, with an odds ratio indicating a 1.4-fold (95% CI: 1.1-1.7) increase for every 0.01-unit increase in RPR.
The RPR index is a simple, helpful tool for evaluating FALD severity in Fontan patients.
Publisher
Termedia Publishing House
